BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2724420)

  • 1. Characterization of a YAC-1 mouse cell receptor for group B coxsackieviruses.
    Hsu KH; Crowell RL
    J Virol; 1989 Jul; 63(7):3105-8. PubMed ID: 2724420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses.
    de Verdugo UR; Selinka HC; Huber M; Kramer B; Kellermann J; Hofschneider PH; Kandolf R
    J Virol; 1995 Nov; 69(11):6751-7. PubMed ID: 7474086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese hamster ovary cells are non-permissive towards infection with coxsackievirus B3 despite functional virus-receptor interactions.
    Kramer B; Huber M; Kern C; Klingel K; Kandolf R; Selinka HC
    Virus Res; 1997 May; 48(2):149-56. PubMed ID: 9175253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
    Martino TA; Petric M; Brown M; Aitken K; Gauntt CJ; Richardson CD; Chow LH; Liu PP
    Virology; 1998 May; 244(2):302-14. PubMed ID: 9601501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor proteins on newborn Balb/c mouse brain cells for coxsackievirus B3 are immunologically distinct from those on HeLa cells.
    Xu R; Mohanty JG; Crowell RL
    Virus Res; 1995 Mar; 35(3):323-40. PubMed ID: 7785319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of the putative coxsackievirus B receptor from HeLa cells.
    Carson SD; Chapman NN; Tracy SM
    Biochem Biophys Res Commun; 1997 Apr; 233(2):325-8. PubMed ID: 9144533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus.
    Martino TA; Petric M; Weingartl H; Bergelson JM; Opavsky MA; Richardson CD; Modlin JF; Finberg RW; Kain KC; Willis N; Gauntt CJ; Liu PP
    Virology; 2000 May; 271(1):99-108. PubMed ID: 10814575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.
    Goodfellow IG; Evans DJ; Blom AM; Kerrigan D; Miners JS; Morgan BP; Spiller OB
    J Virol; 2005 Sep; 79(18):12016-24. PubMed ID: 16140777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of a HeLa cell receptor protein for group B coxsackieviruses.
    Mapoles JE; Krah DL; Crowell RL
    J Virol; 1985 Sep; 55(3):560-6. PubMed ID: 2991580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of the deoxycholate-solubilized HeLa cell plasma membrane receptor for binding group B coxsackieviruses.
    Krah DL; Crowell RL
    J Virol; 1985 Mar; 53(3):867-70. PubMed ID: 2983096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses.
    Hsu KH; Lonberg-Holm K; Alstein B; Crowell RL
    J Virol; 1988 May; 62(5):1647-52. PubMed ID: 2451756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of a receptor protein involved in attachment of human rhinoviruses.
    Tomassini JE; Colonno RJ
    J Virol; 1986 May; 58(2):290-5. PubMed ID: 3009846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of an antigenic adenovirus epitope in a group B coxsackievirus.
    Höfling K; Tracy S; Chapman N; Kim KS; Smith Leser J
    J Virol; 2000 May; 74(10):4570-8. PubMed ID: 10775593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses.
    Tomko RP; Xu R; Philipson L
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3352-6. PubMed ID: 9096397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice.
    Tracy S; Höfling K; Pirruccello S; Lane PH; Reyna SM; Gauntt CJ
    J Med Virol; 2000 Sep; 62(1):70-81. PubMed ID: 10935991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of B lymphocytes in coxsackievirus B3 infection.
    Mena I; Perry CM; Harkins S; Rodriguez F; Gebhard J; Whitton JL
    Am J Pathol; 1999 Oct; 155(4):1205-15. PubMed ID: 10514403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coxsackie B virus and its interaction with permissive host cells.
    Selinka HC; Huber M; Pasch A; Klingel K; Aepinus C; Kandolf R
    Clin Diagn Virol; 1998 Apr; 9(2-3):115-23. PubMed ID: 9645993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of 125I-labeled reovirus to cell surface receptors.
    Epstein RL; Powers ML; Rogart RB; Weiner HL
    Virology; 1984 Feb; 133(1):46-55. PubMed ID: 6702106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acanthamoeba castellanii promotion of in vitro survival and transmission of coxsackie b3 viruses.
    Mattana A; Serra C; Mariotti E; Delogu G; Fiori PL; Cappuccinelli P
    Eukaryot Cell; 2006 Apr; 5(4):665-71. PubMed ID: 16607014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A solid-phase assay of solubilized HeLa cell membrane receptors for binding group B coxsackieviruses and polioviruses.
    Krah DL; Crowell RL
    Virology; 1982 Apr; 118(1):148-56. PubMed ID: 6281966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.